Ipsen holds symposium at new headquarters

French drugmaker Ipsen held an international scientific symposium on biomedical research at its new corporate headquarters in  Boulogne-Billancourt, near Paris.

The meeting was chaired by two of the most prominent personalities in  French science: Jean-Pierre Changeux, member of the Academie des  Sciences who was behind basic research on acetylcholine receptors and  Nicole Le Douarin, pioneer of embryology research and the center's  secretary. Other scientists who have been instrumental in the evolution  of knowledge, such as Professor Roger Guillemin, Nobel Prize Laureate of  Medicine and Director of the Salk Institute, one of Ipsen's partners,  also attended the symposium.

Chief executive Jean-Luc Belingard said: "we are extremely proud and  honored to welcome these key individuals who have significantly marked  the life sciences landscape, to our new headquarters. The caliber of the  scientists presenting at this meeting is testament to Ipsen's  longstanding commitment, alongside the academic community, to meet  today's new biomedical challenges. The drive to develop new drugs to  treat the huge unmet medical needs we still see today requires strong  collaboration between all stakeholders, including the academic community  and the pharmaceutical industry."